Cowen and Company
6
132M
5
0.06
1
0.17
3
- Areas of investment
Summary
Cowen and Company is the famous Corporate Investor, which was founded in 1918. The main office of represented Corporate Investor is situated in the New York. The company was established in North America in United States.
We also calculated 5 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight Horizon Pharma. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical.
The higher amount of exits for fund were in 2011. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2014. The usual things for fund are deals in the range of more than 100 millions dollars.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Cowen and Company, startups are often financed by Sutter Hill Ventures, Pequot Capital, Essex Woodlands Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Citigroup Global Markets.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 3
- Rounds per year
- 0.06
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (4)
- Pharmaceutical (3)
- Therapeutics (3)
- Health Care (2)
- Medical (1) Show 4 more
- Investments by region
-
- United States (5)
- Canada (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 1.00
- Strategy success index
- 0.56
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Omega Therapeutics | 30 Mar 2021 | Biotechnology, Health Care | Late Stage Venture | 126M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.